NM_001163941.2:c.662C>T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001163941.2(ABCB5):c.662C>T(p.Ala221Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000762 in 1,613,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001163941.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000134 AC: 33AN: 246044Hom.: 0 AF XY: 0.000127 AC XY: 17AN XY: 133748
GnomAD4 exome AF: 0.0000780 AC: 114AN: 1461580Hom.: 0 Cov.: 32 AF XY: 0.0000798 AC XY: 58AN XY: 727058
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152292Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.662C>T (p.A221V) alteration is located in exon 7 (coding exon 6) of the ABCB5 gene. This alteration results from a C to T substitution at nucleotide position 662, causing the alanine (A) at amino acid position 221 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at